Financial Performance Analysis of Pharmaceutical Industry in India

Author(s)	Dr. Kanchan, Teena Verma
Country	India
Abstract	The financial assessment of a company has been the topic of debate among policy leaders as administrators, planners, economists and research workers for several years. It is a method of calculating the effects of monetary policies and activities of a company. Financial performance review shall involve the examination and evaluation of the financial results in such a manner as to allow a complete diagnostic of the viability and financial soundness of the company. This study is based upon the 5 Pharma companies i.e., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Limited, Cipla Limited, Lupin Limited and Aurobindo Pharma Limited were selected for the study with the period of study from March 2016 to March 2020. The ANOVA analysis result revealed that there is a significant difference in the Profit of the selected pharmaceutical companies during the period of study.
Keywords	Financial Performance, Pharmaceutical Companies, ANOVA Analysis, India
Field	Mathematics > Economy / Commerce
Published In	Volume 4, Issue 5, September-October 2022
Published On	2022-09-26
Cite This	Financial Performance Analysis of Pharmaceutical Industry in India - Dr. Kanchan, Teena Verma - IJFMR Volume 4, Issue 5, September-October 2022. DOI 10.36948/ijfmr.2022.v04i05.999
DOI	https://doi.org/10.36948/ijfmr.2022.v04i05.999
Short DOI	https://doi.org/gq7sjt

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research